Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00038311
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Sarcoma
Interventions
DRUG:
PN-152,243)/PN-196,444
Sponsor
Pfizer